Phase I trial in recurrent high-grade glioma: High-dose vorinostat with concurrent hypofractionated radiation therapy

Informazioni relative al progetto

RECURRENT GLIOMA TX

ID dell’accordo di sovvenzione: 303795

Progetto chiuso

Data di avvio 1 Gennaio 2013

Data di completamento 31 Dicembre 2016

Finanziato da

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 100 000,00

Contributo UE € 100 000,00

Coordinato da

MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER
Israel